The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEagle Eye Regulatory News (EYE)

Share Price Information for Eagle Eye (EYE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 480.00
Ask: 490.00
Change: -5.00 (-1.02%)
Spread: 10.00 (2.083%)
Open: 490.00
High: 490.00
Low: 485.00
Prev. Close: 490.00
EYE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of share options

9 Apr 2021 16:33

RNS Number : 0391V
Eagle Eye Solutions Group PLC
09 April 2021
 

 

9 April 2021

 

Eagle Eye Solutions Group plc

("Eagle Eye", the "Group", or the "Company")

 

Issue of share options

 

Eagle Eye, a leading SaaS technology company that creates digital connections enabling personalised, real-time marketing through coupons, loyalty, apps, subscriptions and gift services, announces that the following options over ordinary shares of 1p each in Eagle Eye ("Ordinary Shares") were granted on 8 April 2021 to the following Executive Directors and person discharging managerial responsibilities ("PDMRs") of Eagle Eye for nil cost as follows:

 

Director/PDMR

Role

Number of Ordinary Shares subject to option grant

Total number of Ordinary Shares under option post grant

% of existing issued share capital

Tim Mason

CEO

142,662

1,729,908

6.6%

Steve Rothwell

CTO

82,412

831,759

3.2%

Lucy Sharman-Munday

CFO

82,412

662,480

2.5%

Al Henderson

CSO

37,876

304,041

1.2%

David Aylmer

COO

47,911

350,426

1.3%

 

These awards have been made under the Eagle Eye Group Solutions Plc Long Term Incentive Plan scheme with an exercise price of 1p per Ordinary Share and have been granted under the current year's Long Term Incentive Plan performance criteria, vesting following completion of the financial year ending 30 June 2023 subject to revenue and EBITDA performance criteria and the overall underlying performance of the Company. In common with previous awards, the number of options which vest will vary depending on the level of achievement between threshold, target and stretch performance levels.

Following the new grant of options and assuming all vesting criteria is met, the fully diluted number of Ordinary Shares would be 30,594,498; of which the total number of Ordinary Shares over which options currently issued and outstanding represent 14.7% of the fully diluted number of Ordinary Shares. This is in accordance with the Company's shareholder approved limit for shares outstanding under the Company's share option schemes at any time of a maximum of 20% of the ordinary share capital of the Company in issue at such time.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

 

Name

1. Tim Mason

2. Steve Rothwell

3. Lucy Sharman-Munday

4. Al Henderson

5. David Aylmer

2

Reason for the notification

a)

 

 

Position/status

1. Chief Executive Officer

2. Chief Technology Officer

3. Chief Financial Officer

4. Chief Sales Officer

5. Chief Operating Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eagle Eye Solutions Group plc

b)

LEI

2138002S1AIBVVMZ7A21

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 

 

Options over Ordinary shares of 1p each

 

GB00BKF1YD83

b)

Nature of transaction

Grant of Options

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

1. 142,662

2. 82,412

3. 82,412

4. 37,876

5. 47,911

Aggregated information

- Aggregated volume

- Price

 

Not applicable

e)

Date of the transaction

8 April 2021

f)

Place of the transaction

Outside of a trading venue

 

 

For further information, please contact:

 

Eagle Eye

Tim Mason, Chief Executive Officer

Lucy Sharman-Munday, Chief Financial Officer

 

 

Tel: 0844 824 3686

Investec (Nominated Advisor and Joint Broker)

Corporate Finance: David Anderson/ Sebastian Lawrence

Corporate Broking: Sara Hale/ Toba Fatimilehin

Tel: 020 7597 5970

 

Shore Capital (Joint Broker)

Corporate Finance: Hugh Morgan/ Daniel Bush/ Sarah Mather

Corporate Broking: Henry Willcocks

Tel: 020 7408 4090

Alma PR

Caroline Forde, Robyn Fisher, Molly Gretton

 

Tel: 020 3405 0205

 

About Eagle Eye

 

Eagle Eye is a leading SaaS technology company transforming marketing by creating digital connections that enable personalised performance marketing in real time through coupons, loyalty, apps, subscriptions and gift services. 

 

Eagle Eye AIR enables the secure issuance and redemption of digital offers and rewards at scale, across multiple channels, enabling a single customer view. We create a network between merchants, brands and audiences to enable customer acquisition, interaction and retention at lower cost whilst driving marketing innovation.

 

The Company's current customer base comprises leading names in UK Grocery, Retail, Leisure and Food & Beverage sectors, including Asda, Sainsbury's, Tesco, Waitrose and John Lewis & Partners, Virgin Red, JD Sports, Pret a Manger, Greggs, Mitchells & Butlers, Pizza Express; in North America, Loblaws, Shoppers Drug Mart and Southeastern Grocers and in Australia & New Zealand, Woolworths Group and The Warehouse Group.

 

 

For more information, please visit www.eagleeye.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKCBBPBKDCQK
Date   Source Headline
17th Nov 20207:00 amRNSAGM Statement
13th Nov 20202:20 pmRNSIssue of Equity
11th Nov 20207:00 amRNSFive-year contract with Woolworths Group
22nd Oct 20206:12 pmRNS2020 Annual Report & Accounts and Notice of AGM
18th Sep 20207:00 amRNSEagle Eye powers Pret A Manger coffee subscription
17th Sep 202011:35 amRNSIssue of Equity
16th Sep 20207:00 amRNSFinal Results
28th Jul 20208:06 amRNSHolding(s) in Company
23rd Jul 20203:59 pmRNSHolding(s) in Company
16th Jul 20207:00 amRNSTrading Update
1st Jun 202010:59 amRNSDirector/PDMR Shareholding
29th May 202012:32 pmRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTrading Update and Contract extensions
17th Mar 20207:00 amRNSInterim Results
14th Feb 20207:00 amRNSIssue of Share Options
7th Feb 20202:40 pmRNSIssue of Equity
6th Feb 20204:37 pmRNSIssue of Equity
4th Feb 20205:42 pmRNSIssue of Equity - Replacement
3rd Feb 20204:44 pmRNSIssue of Equity
31st Jan 20204:50 pmRNSIssue of Equity
29th Jan 20207:49 amRNSDirector Declaration
28th Jan 20207:00 amRNSH1 Trading Update
20th Dec 20197:00 amRNSFirst US Customer
14th Nov 20195:59 pmRNSResult of AGM
14th Nov 20197:00 amRNSAGM Statement
18th Oct 20194:43 pmRNS2019 Annual Report & Accounts and Notice of AGM
25th Sep 20195:20 pmRNSHolding(s) in Company
19th Sep 20195:57 pmRNSDirector dealings
18th Sep 201911:25 amRNSThree-year contract with a leading NZ Retailer
17th Sep 20197:00 amRNSFinal Results
19th Jul 20194:42 pmRNSIssue of Equity
18th Jul 20197:00 amRNSTrading Update
14th May 20197:00 amRNSEagle Eye and News America Marketing Partnership
10th Apr 20195:10 pmRNSDirector/PDMR Shareholding
4th Apr 20192:40 pmRNSDirector/PDMR Shareholding
28th Mar 20192:35 pmRNSDirector/PDMR Shareholding
13th Mar 20195:00 pmRNSPDMR Shareholding
13th Mar 20197:00 amRNSInterim Results
23rd Jan 20194:30 pmRNSIssue of Equity
23rd Jan 20192:00 pmRNSPDMR Shareholding
23rd Jan 20197:00 amRNSTrading Update
9th Jan 20196:23 pmRNSPDMR Shareholding
9th Jan 20191:46 pmRNSPDMR Shareholding
8th Jan 20194:51 pmRNSIssue of share options
7th Jan 20197:00 amRNSContract Win
2nd Jan 20197:00 amRNSAppointment of Joint Broker
22nd Nov 20187:00 amRNSCapital Markets Event
16th Nov 20184:51 pmRNSResult of AGM
16th Nov 20187:00 amRNSAGM Statement
16th Nov 20187:00 amRNSNon-Executive Director Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.